TrialDiabetes technology & therapeutics2012

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.

Paolo Rossetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.